Longevity Health Holdings, Inc.
For the period ended Mar 31, 2026. Filed May 15, 2026.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Mar 31, 2026 · Filed May 15, 2026
XAGE$0.130.0%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Condensed Consolidated Statements of Stockholders’ Deficit
Three Months Ended March 31, 2026 and 2025
| Common Stock · Additional Paid-in · Accumulated | |||||
|---|---|---|---|---|---|
| Shares | Amount | Capital | Deficit | Total | |
| Balance at January 1, 2026 | 1,781,738 | $178 | $69,909,893 | $(75,776,944) | $(5,866,873) |
| Common Stock issued, net of costs | 689,656 | 69 | 189,932 | — | 190,001 |
| Common Stock issued/issuable for Elevai Acquisition | 3,927 | — | 67,742 | — | 67,742 |
| Stock-based compensation expense | — | — | 145,927 | — | 145,927 |
| Net loss | — | — | — | (1,431,713) | (1,431,713) |
| Balance at March 31, 2026 | 2,475,321 | $247 | $70,313,494 | $(77,208,657) | $(6,894,916) |
| Balance at January 1, 2025 | 696,969 | $70 | $64,158,930 | $(68,871,662) | $(4,712,662) |
| Common Stock issued, net of costs | 268,840 | 26 | 1,637,584 | — | 1,637,610 |
| Common Stock issued/issuable for Elevai Acquisition | 38,308 | 4 | 660,801 | — | 660,805 |
| Stock-based compensation expense | — | — | 114,829 | — | 114,829 |
| Net loss | — | — | — | (1,505,867) | (1,505,867) |
| Balance at March 31, 2025 | 1,004,117 | $100 | $66,572,144 | $(70,377,529) | $(3,805,285) |
-5-
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.